4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells-Reference-Cited by-同舟云学术

4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells

Published:2021-07 Issue: Volume:422 Page:115493
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Satriyo Pamungkas Bagus,Su Chih Ming,Ong Jiann Ruey,Huang Wen-Chien,Fong Iat-Hang,Lin Chih-Cheng,Aryandono Teguh,Haryana Sofia Mubarika,Deng Li,Huang Chun-Chih,Tzeng Yew-Min,Chao Tsu-Yi,Liu Hui-Wen,Yeh Chi-Tai

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference25 articles.

1. Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence;Balko;Sci. Transl. Med.,2016

2. 4-acetyl-antroquinonol B suppresses SOD2-enhanced cancer stem cell-like phenotypes and chemoresistance of colorectal cancer cells by inducing hsa-miR-324 re-expression;Bamodu;Cancers (Basel),2018

3. Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94;Caccuri;Cancers (Basel).,2019

4. Overall Cdk activity modulates the DNA damage response in mammalian cells;Cerqueira;J. Cell Biol.,2009

5. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype;Chang;Toxicol. Appl. Pharmacol.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Assessment of 4-Acetyl-Antroquinonol B and Erinacine A in Suppressing Breast Cancer-Induced Osteoclastogenesis;International Journal of Medicinal Mushrooms;2024

2. A comparative study of Bazedoxifene, Exemestane, Fulvestrant, Raloxifene, Tryprostatin A, and Vorinostat compounds as potential inhibitors against breast cancer through molecular docking, and molecular dynamics simulation;Chinese Journal of Analytical Chemistry;2023-10

3. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer;Journal of Advanced Research;2023-09

4. Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy;Recent Patents on Anti-Cancer Drug Discovery;2023-05

5. A review on the role of cyclin dependent kinases in cancers;Cancer Cell International;2022-10-20